» Articles » PMID: 12853400

Analytical Performance of a Highly Sensitive C-reactive Protein-based Immunoassay and the Effects of Laboratory Variables on Levels of Protein in Blood

Overview
Date 2003 Jul 11
PMID 12853400
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

C-reactive protein (CRP) is an acute-phase reactant whose levels increase in response to a variety of inflammatory stimuli. Elevated levels in serum are observed after trauma, tissue necrosis, infection, surgery, and myocardial infarction and are associated with an increased risk of cardiovascular disease. CRP levels are also elevated in noninflammatory states, such as obesity, sleep disturbances, depression, chronic fatigue, aging, and physical inactivity. In this study, the performance of a highly sensitive CRP enzyme immunoassay was evaluated, along with common laboratory variables (specimen type, processing time, and storage conditions) that may influence measured blood concentrations of CRP. The measurement range of the assay was from 0.4 to 50 microg/liter. Total imprecision (coefficient of variation) ranged from 8.1 to 11.4%. CRP levels obtained with the enzyme immunoassay were highly correlated with those obtained with an automated immunonephelometric assay. Comparable results were obtained for plasma (heparin and EDTA treated) and serum samples, and levels were unaffected by delays in sample processing and storage temperature. CRP levels were also unaffected by up to seven freeze-thaw cycles. The median CRP concentration in healthy adults was determined to be 0.94 mg/liter, with a 95% working reference interval of 0 to 6.9 mg/liter. In view of these data, we recommend that serial serum or plasma samples for CRP should be stored at 4 degrees C for short periods of time or at -70 degrees C for longer periods and tested within the same run to minimize interassay variability.

Citing Articles

Does sex moderate the effects of early life stress on peripheral inflammation in alcohol use disorder? A preliminary investigation.

Kirsch D, Grodin E, Gillis A, Miotto K, Ray L Drug Alcohol Depend. 2024; 265:112474.

PMID: 39490200 PMC: 11824112. DOI: 10.1016/j.drugalcdep.2024.112474.


Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder.

Kirsch D, Grodin E, Nieto S, Kady A, Ray L Neuropsychopharmacology. 2024; 49(11):1719-1728.

PMID: 38740901 PMC: 11399383. DOI: 10.1038/s41386-024-01877-4.


Evaluation of Systemic Inflammation Before and After Standard Anti-tuberculosis Treatment in Patients With Active Pulmonary Tuberculosis and Diabetes Mellitus.

Lopez-Gonzalez J, Martinez-Soto J, Avila-Cervantes C, Mata-Pineda A, Alvarez-Hernandez G, Alvarez-Meza J Cureus. 2024; 16(3):e55391.

PMID: 38562330 PMC: 10984244. DOI: 10.7759/cureus.55391.


C-reactive protein: a target for therapy to reduce inflammation.

Rizo-Tellez S, Sekheri M, Filep J Front Immunol. 2023; 14:1237729.

PMID: 37564640 PMC: 10410079. DOI: 10.3389/fimmu.2023.1237729.


Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives.

Melnikov I, Kozlov S, Saburova O, Avtaeva Y, Guria K, Gabbasov Z Int J Mol Sci. 2023; 24(3).

PMID: 36768404 PMC: 9917083. DOI: 10.3390/ijms24032079.


References
1.
Yu H, Rifai N . High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem. 2001; 33(8):601-10. DOI: 10.1016/s0009-9120(00)00186-7. View

2.
Macy E, Hayes T, Tracy R . Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997; 43(1):52-8. View

3.
Smith J, Dykes R, Douglas J, Krishnaswamy G, Berk S . Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 1999; 281(18):1722-7. DOI: 10.1001/jama.281.18.1722. View

4.
Their M, Ronnholm K, Sairanen H, Holmberg C, Jalanko H . Serum C-reactive protein in pediatric kidney and liver transplant patients. Pediatr Transplant. 2002; 6(2):153-60. DOI: 10.1034/j.1399-3046.2002.01071.x. View

5.
Volanakis J . Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001; 38(2-3):189-97. DOI: 10.1016/s0161-5890(01)00042-6. View